Botulinum toxin as a biological weapon: medical and public health management
- PMID: 11209178
- DOI: 10.1001/jama.285.8.1059
Botulinum toxin as a biological weapon: medical and public health management
Erratum in
- JAMA 2001 Apr 25;285(16):2081
Abstract
Objective: The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if botulinum toxin is used as a biological weapon against a civilian population.
Participants: The working group included 23 representatives from academic, government, and private institutions with expertise in public health, emergency management, and clinical medicine.
Evidence: The primary authors (S.S.A. and R.S.) searched OLDMEDLINE and MEDLINE (1960-March 1999) and their professional collections for literature concerning use of botulinum toxin as a bioweapon. The literature was reviewed, and opinions were sought from the working group and other experts on diagnosis and management of botulism. Additional MEDLINE searches were conducted through April 2000 during the review and revisions of the consensus statement.
Consensus process: The first draft of the working group's consensus statement was a synthesis of information obtained in the formal evidence-gathering process. The working group convened to review the first draft in May 1999. Working group members reviewed subsequent drafts and suggested additional revisions. The final statement incorporates all relevant evidence obtained in the literature search in conjunction with final consensus recommendations supported by all working group members.
Conclusions: An aerosolized or foodborne botulinum toxin weapon would cause acute symmetric, descending flaccid paralysis with prominent bulbar palsies such as diplopia, dysarthria, dysphonia, and dysphagia that would typically present 12 to 72 hours after exposure. Effective response to a deliberate release of botulinum toxin will depend on timely clinical diagnosis, case reporting, and epidemiological investigation. Persons potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months. Treatment with antitoxin should not be delayed for microbiological testing.
Similar articles
-
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.JAMA. 2000 May 3;283(17):2281-90. doi: 10.1001/jama.283.17.2281. JAMA. 2000. PMID: 10807389 Review.
-
Management of botulism.Ann Pharmacother. 2003 Jan;37(1):127-31. doi: 10.1345/aph.1C034. Ann Pharmacother. 2003. PMID: 12503947 Review.
-
Tularemia as a biological weapon: medical and public health management.JAMA. 2001 Jun 6;285(21):2763-73. doi: 10.1001/jama.285.21.2763. JAMA. 2001. PMID: 11386933 Review.
-
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.JAMA. 1999 May 12;281(18):1735-45. doi: 10.1001/jama.281.18.1735. JAMA. 1999. PMID: 10328075 Review.
-
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.JAMA. 1999 Jun 9;281(22):2127-37. doi: 10.1001/jama.281.22.2127. JAMA. 1999. PMID: 10367824 Review.
Cited by
-
The efficacy and safety of neubotulinumtoxinA for the treatment of forehead horizontal lines in Asians - A clinical, prospective, interventional, split-face study.Skin Res Technol. 2024 Apr;30(4):e13644. doi: 10.1111/srt.13644. Skin Res Technol. 2024. PMID: 38533764 Free PMC article.
-
Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana.Hum Vaccin Immunother. 2024 Dec 31;20(1):2329446. doi: 10.1080/21645515.2024.2329446. Epub 2024 Mar 25. Hum Vaccin Immunother. 2024. PMID: 38525945 Free PMC article.
-
Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril?Curr Pharm Des. 2024;30(8):578-588. doi: 10.2174/0113816128284720240212111926. Curr Pharm Des. 2024. PMID: 38409723 Review.
-
Detection of botulinum neurotoxin A (BoNT/A) enzymatic activity by pregnancy test strips based on hCG-modified magnetic nanoparticles.Mikrochim Acta. 2024 Jan 29;191(2):114. doi: 10.1007/s00604-024-06197-4. Mikrochim Acta. 2024. PMID: 38286853
-
Rare Case of Botulism and Dysphagia: The Role of Physical and Rehabilitation Medicine.Cureus. 2023 Nov 17;15(11):e48964. doi: 10.7759/cureus.48964. eCollection 2023 Nov. Cureus. 2023. PMID: 38106719 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous